"4:34 pm Endo Intl announces it will enter into a program to repurchase up to $250 mln of its common stock and pursue M&A's of up to $1bln under a previously authorized $2.5 bln purchase plan."
Heard ENDP to offer $19.99/ share for BDSI?
1) Sirgo's track record includes starting, growing, and then selling the business.
2) Hiring former Salix sales and marketing officers to grow Bunavail and Onsolis revenues (Salix was acquired by Valeant earlier this year).
Analysts' target at $14 per share.
Endo Pharma will scoop it up for pennies on the dollar....or hope for a bidding war with other would-be suitors.
Might cause a bidding war with ENDP.
Bottom is in!
Late October? Mid November? Early December?
PDUFA October 23.